ADVERTISEMENT
News
Antibiotic Tablets Recalled
06/03/2020
Recalled are 100-mg doxycycline hyclate tablets manufactured by West-Ward Pharmaceuticals Corp. and packaged in:
- 50-count bottles (NDC 0143-2112-50) from lot 71846B (Exp. 6/21); and
- 500-count bottles (NDC 0143-2112-05) from lots 71726A (Exp. 6/20), 71846B (Exp. 6/21), and 71853A (Exp. 6/21).
Also recalled are 100-mg doxycycline hyclate tablets by PD-Rx Pharmaceuticals Inc. and packaged in:
- 6-count bottles (NDC 55289-866-06) from lot L18B72, (Exp. 12/31/20);
- 10-count bottles (NDC 55289-866-10) from lot I18B83 (Exp. 6/30/20);
- 14-count bottles (NDC 55289-866-14) from lots H18B11 (Exp. 6/30/20), I18A53 (Exp. 6/30/20), J18F97 (Exp. 10/31/20), K18A33 (Exp. 11/30/20), K18D17 (Exp. 11/30/20), L18A11 (Exp. 12/31/20), L18A29 (Exp. 12/31/20), and L18D81 (Exp. 12/31/20);
- 20-count bottles (NDC 55289-866-20) from lots H18F60 (Exp. 6/30/20), I18C26 (Exp. 6/30/20), I18D61 (Exp. 6/30/20), J18B80 (Exp. 10/31/20), K18C97 (Exp. 11/30/20), L18B30 (Exp. 12/31/20), L18D25 (Exp. 12/31/20), and L18E50 (Exp. 12/31/20);
- 28-count bottles (NDC 55289-866-28) from lots I18D07 (Exp. 6/30/20), J1E02 (Exp. 10/31/20), J18E62 (Exp. 10/31/20), K18E98 (Exp. 11/30/20), and L18C54 (Exp 12/31/20);
- 30-count bottles (NDC 55289-866-30) from lots H18E18 (Exp. 6/30/20), I18F94 (Exp. 9/30/20), J18E42 (Exp. 10/31/20), and L18B56 (Exp. 12/31/20);
- 60-count bottles (NDC 55289-866-60) from lots J18C84 (Exp. 10/31/20) and A19B70 (Exp. 1/31/21);
- 120-count bottles (NDC 55289-866-98) from lot K18E92 (Exp. 11/30/20);
- 210-count bottles (NDC 55289-866-71) from lots I18E80 (Exp. 6/30/20) and K18A19 (Exp. 11/30/20);
- 300-count bottles (NDC 55289-866-87) from lots F18E11 (Exp. 6/30/20), G18E66 (Exp. 6/30/20), H18E72 (Exp. 06/30/20), I18E75 (Exp. 9/30/20), I18E95 (Exp. 9/30/20), and I18F64 (Exp. 9/30/20); and
- 400-count bottles (NDC 55289-866-74) from lots A19D44 (Exp. 8/31/20), H18E76 (Exp. 6/30/20), I18F21 (Exp. 9/30/20), and L18B91 (Exp. 12/31/20).
All doxycycline hyclate tablets included in the recalls were distributed in the United States.
West-Ward initiated the voluntary recalls in mid-May. On May 26, 2020, the FDA designated the recalls Class II. Under Class II recalls, use of the product could cause temporary or medically reversible adverse health consequences, or a remote possibility of serious harm.
Doxycycline is a prescription antibiotic used to treat bacterial infections.
—Jolynn Tumolo